NCT03804671View on ClinicalTrials.gov

A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

March 26, 2019

Study Completion Date

March 26, 2019

Conditions
Healthy
Interventions
DRUG

BI 730357

Oral dose

DRUG

BI 730357 mixed with [C-14] BI 730357 BS

Intravenous dose

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY